Cancer Health Treatment Update Happy Thanksgiving from Cancer Health and Smart + Strong. Cancer Health Treatment Update Four-Week Cancer Treatment Delay Tied to Increased Mortality Risk Longer delays were associated with a worsening risk of death. FDA Approves Keytruda Plus Chemo for Triple-Negative Breast Cancer First-line treatment with immunotherapy and a chemotherapy regimen extended progression-free survival by 35%. Men With Breast Cancer Fare Better if Diagnosed Earlier Black men with breast cancer were more likely to be diagnosed at a later stage. Lung Microbiome May Affect Lung Cancer Pathogenesis and Prognosis Enrichment of the lungs with oral commensal microbes is associated with negative effects in patients with lung cancer. Travel on Thanksgiving? Pass the COVID Doctors and health officials share advice on how to handle Thanksgiving during the pandemic. Third COVID-19 Vaccine Is Up to 90% Effective The vaccine from the University of Oxford and AstraZeneca uses a chimpanzee adenovirus vector. More News About COVID-19 For more news about the novel coronavirus and COVID-19, including how it affects people living with cancer, visit our sister site, COVID Health. Cancer Health Fall 2020 Check out our latest print edition! Advertisement Newsfeed Teenage Chef Ben Watkins Dies of Rare Cancer Many Americans Plan to Gather for the Holidays During COVID-19 IVF and Other Reproductive Technologies Do Not Boost Ovarian Cancer Risk Third COVID-19 Vaccine Is Up to 90% Effective Blog: Food and Drug Administration (FDA) Breast Cancer Screening: Thermogram No Substitute for Mammogram FDA Issues Alert About Tecentriq Plus Paclitaxel for Breast Cancer FDA Approves Onureg for Acute Myeloid Leukemia FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma Newsfeed Teenage Chef Ben Watkins Dies of Rare Cancer Many Americans Plan to Gather for the Holidays During COVID-19 IVF and Other Reproductive Technologies Do Not Boost Ovarian Cancer Risk Third COVID-19 Vaccine Is Up to 90% Effective Blog: Food and Drug Administration (FDA) Breast Cancer Screening: Thermogram No Substitute for Mammogram FDA Issues Alert About Tecentriq Plus Paclitaxel for Breast Cancer FDA Approves Onureg for Acute Myeloid Leukemia FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: